Seth P. Harlow

The Sentinel Node in Breast Cancer — A Multicenter Validation Study

David N. Krag, Donald L. Weaver, Takamaru Ashikaga et al. · New England Journal of Medicine · 1998 · 2K citations · Full text

Medicine, Oncology, Surgery +17

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2010 · 1.9K citations · Full text

Medicine, Oncology, Surgery +17

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2007 · 1.1K citations

Medicine, Oncology, Surgery +17

Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

Takamaru Ashikaga, David N. Krag, Stephanie R. Land et al. · Journal of Surgical Oncology · 2010 · 509 citations · Full text

Medicine, Oncology, Surgery +13

Effect of Occult Metastases on Survival in Node-Negative Breast Cancer

Donald L. Weaver, Takamaru Ashikaga, David N. Krag et al. · New England Journal of Medicine · 2011 · 434 citations · Full text

Medicine, Oncology, Surgery +14